应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MREO Mereo Biopharma Group Plc
盘前交易 02-10 09:19:39 EST
0.3880
-0.0365
-8.60%
盘前
0.3871
-0.0009
-0.23%
09:19 EST
最高
0.4066
最低
0.3639
成交量
525.67万
今开
0.4050
昨收
0.4245
日振幅
10.06%
总市值
6,174万
流通市值
3,898万
总股本
1.59亿
成交额
201.63万
换手率
5.23%
流通股本
1.00亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Mereo Biopharma Group Plc盘中异动 股价大涨5.55%
市场透视 · 02-06
Mereo Biopharma Group Plc盘中异动 股价大涨5.55%
Mereo Biopharma Group Plc盘中异动 早盘股价大跌5.32%
市场透视 · 2025-12-31
Mereo Biopharma Group Plc盘中异动 早盘股价大跌5.32%
华尔街顶级分析师最新评级:DigitalBridge遭下调评级
环球市场播报 · 2025-12-31
华尔街顶级分析师最新评级:DigitalBridge遭下调评级
Mereo Biopharma Group Plc盘中异动 股价大涨5.00%
市场透视 · 2025-12-22
Mereo Biopharma Group Plc盘中异动 股价大涨5.00%
Mereo Biopharma Group Plc盘中异动 早盘快速上涨5.73%报2.03美元
市场透视 · 2025-12-19
Mereo Biopharma Group Plc盘中异动 早盘快速上涨5.73%报2.03美元
Mereo BioPharma第三季度净损失为702.4万美元
投资观察 · 2025-11-20
Mereo BioPharma第三季度净损失为702.4万美元
Mereo BioPharma第三季度净收入为-702.4万美元
投资观察 · 2025-11-11
Mereo BioPharma第三季度净收入为-702.4万美元
Mereo Biopharma Group Plc2025财年第二财季实现净利润-14.79百万美元,同比减少20.54%
市场透视 · 2025-08-18
Mereo Biopharma Group Plc2025财年第二财季实现净利润-14.79百万美元,同比减少20.54%
Mereo Biopharma Group Plc盘中异动 快速下挫5.14%
市场透视 · 2025-03-07
Mereo Biopharma Group Plc盘中异动 快速下挫5.14%
Mereo Biopharma Group Plc盘中异动 下午盘股价大涨5.39%
市场透视 · 2025-03-05
Mereo Biopharma Group Plc盘中异动 下午盘股价大涨5.39%
Mereo Biopharma Group Plc盘中异动 早盘急速拉升5.16%
市场透视 · 2025-02-26
Mereo Biopharma Group Plc盘中异动 早盘急速拉升5.16%
Mereo Biopharma Group Plc盘中异动 急速下跌5.02%报2.56美元
市场透视 · 2025-02-25
Mereo Biopharma Group Plc盘中异动 急速下跌5.02%报2.56美元
Mereo Biopharma Group Plc盘中异动 股价大跌5.09%
市场透视 · 2025-02-25
Mereo Biopharma Group Plc盘中异动 股价大跌5.09%
Mereo Biopharma Group Plc盘中异动 股价大涨5.02%
市场透视 · 2025-02-05
Mereo Biopharma Group Plc盘中异动 股价大涨5.02%
Mereo Biopharma Group Plc盘中异动 快速拉升5.05%
市场透视 · 2025-01-30
Mereo Biopharma Group Plc盘中异动 快速拉升5.05%
Mereo Biopharma Group Plc盘中异动 临近午盘大幅下跌5.00%报2.95美元
市场透视 · 2025-01-25
Mereo Biopharma Group Plc盘中异动 临近午盘大幅下跌5.00%报2.95美元
Mereo Biopharma Group Plc盘中异动 急速拉升5.14%报3.07美元
市场透视 · 2025-01-24
Mereo Biopharma Group Plc盘中异动 急速拉升5.14%报3.07美元
Mereo Biopharma Group Plc盘中异动 早盘快速上涨5.94%报3.03美元
市场透视 · 2025-01-21
Mereo Biopharma Group Plc盘中异动 早盘快速上涨5.94%报3.03美元
Mereo Biopharma Group Plc盘中异动 下午盘股价大跌5.61%
市场透视 · 2025-01-17
Mereo Biopharma Group Plc盘中异动 下午盘股价大跌5.61%
Mereo Biopharma Group Plc盘中异动 急速跳水5.69%报3.15美元
市场透视 · 2025-01-14
Mereo Biopharma Group Plc盘中异动 急速跳水5.69%报3.15美元
加载更多
公司概况
公司名称:
Mereo Biopharma Group Plc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Mereo BioPharma Group plc于2015年3月10日根据英格兰和威尔士法律注册成立。该公司是一家专注于罕见病创新疗法开发的生物制药公司。它已经建立了一个后期临床候选产品组合,包括用于成骨不全症的setrusumab和用于α-1抗胰蛋白酶缺乏相关肺部疾病的alvelestat。该公司的战略涉及有选择地获取和开发通过先前研发取得进展的罕见病候选产品。
发行价格:
--
{"stockData":{"symbol":"MREO","market":"US","secType":"STK","nameCN":"Mereo Biopharma Group Plc","latestPrice":0.388,"timestamp":1770670800000,"preClose":0.4245,"halted":0,"volume":5256738,"hourTrading":{"tag":"盘前","latestPrice":0.3871,"preClose":0.388,"latestTime":"09:19 EST","volume":9331,"amount":3632.77729857,"timestamp":1770733177398,"change":-0.0009,"changeRate":-0.00232,"amplitude":0.033505},"delay":0,"changeRate":-0.08598351001177851,"floatShares":100470459,"shares":159131700,"eps":-0.261249,"marketStatus":"盘前交易","change":-0.0365,"latestTime":"02-10 09:19:39 EST","open":0.405,"high":0.4066,"low":0.3639,"amount":2016329.7281637602,"amplitude":0.100589,"askPrice":0.44,"askSize":4448,"bidPrice":0.3602,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.261249,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"adrRate":5,"listingDate":1556078400000,"exchange":"NASDAQ","adjPreClose":0.388,"preHourTrading":{"tag":"盘前","latestPrice":0.3871,"preClose":0.388,"latestTime":"09:19 EST","volume":9331,"amount":3632.77729857,"timestamp":1770733177398,"change":-0.0009,"changeRate":-0.00232,"amplitude":0.033505},"postHourTrading":{"tag":"盘后","latestPrice":0.377,"preClose":0.388,"latestTime":"19:42 EST","volume":44493,"amount":17097.7822,"timestamp":1770684179989,"change":-0.011,"changeRate":-0.028351,"amplitude":0.058763},"volumeRatio":1.2042218052697056,"impliedVol":2.3473,"impliedVolPercentile":0.852},"requestUrl":"/m/hq/s/MREO","defaultTab":"news","newsList":[{"id":"2609548083","title":"Mereo Biopharma Group Plc盘中异动 股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609548083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609548083?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:38","pubTimestamp":1770388698,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日22时38分,Mereo Biopharma Group Plc股票出现异动,股价急速拉升5.55%。截至发稿,该股报0.396美元/股,成交量45.7842万股,换手率0.29%,振幅5.73%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.75%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部在英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020622381895402fe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020622381895402fe0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","MREO"],"gpt_icon":0},{"id":"2600087311","title":"Mereo Biopharma Group Plc盘中异动 早盘股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600087311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600087311?lang=zh_cn&edition=full","pubTime":"2025-12-31 22:43","pubTimestamp":1767192222,"startTime":"0","endTime":"0","summary":"北京时间2025年12月31日22时43分,Mereo Biopharma Group Plc股票出现波动,股价快速下跌5.32%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Vanda Pharmaceuticals Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大,Fibrobiologics, Inc.、Pmgc Holdings Inc.、Gri Bio, Inc.较为活跃,换手率分别为26.39%、22.73%、19.45%,振幅较大的相关个股有Pmgc Holdings Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Vanda Pharmaceuticals Inc.,振幅分别为16.89%、15.91%、15.65%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部在英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025123122434297a0ea3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025123122434297a0ea3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO","BK4139","BK4505"],"gpt_icon":0},{"id":"2595715068","title":"华尔街顶级分析师最新评级:DigitalBridge遭下调评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2595715068","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595715068?lang=zh_cn&edition=full","pubTime":"2025-12-31 00:09","pubTimestamp":1767110940,"startTime":"0","endTime":"0","summary":"华尔街最受热议、影响市场走势的分析师研报评级,现已汇总呈现。以下为 The Fly 整理的、投资者需重点关注的当日最新评级调仓信息。 阿格斯投行将必和必拓评级从‘持有’上调至‘买入’,目标价定为 68 美元。 加拿大皇家银行资本将DigitalBridge评级从‘跑赢行业’下调至‘与行业持平’,目标价从 23 美元下调至 16 美元。该行认为,公司采用成熟供应链的标准化零部件开展研发,有望大幅降低先进核反应堆开发商通常面临的监管与技术壁垒。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a9c5b2ea6477641c148f3bfa413b9f24","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-12-31/doc-inheqyvi5645186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2125909916.SGD","LU2065170008.USD","BK4505","BK4233","BK4613","ERO","BHP","IE00BLDYK493.USD","LU0274383776.USD","MREO","DBRG","LU0054578231.USD","BK4160","LU0963586101.USD","CVLT","RBRK","BK4588","LU0300736062.USD","BK4182","IE00B64QTZ34.USD","LU2065731478.USD","BK4139","LU2125909759.SGD","VRNS","LU2065171311.SGD","BK4168","BK4532","BK4015","LU2065171402.SGD","BK4585","LU1923622291.USD","NKLR","BK4205","LU0300736492.USD","LU2065169927.USD","BK4135","RARE","LU2286300806.USD","BK4097"],"gpt_icon":0},{"id":"2593527884","title":"Mereo Biopharma Group Plc盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593527884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593527884?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:31","pubTimestamp":1766413899,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日22时31分,Mereo Biopharma Group Plc股票出现波动,股价大幅拉升5.00%。截至发稿,该股报2.10美元/股,成交量11.7828万股,换手率0.07%,振幅1.50%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.03%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部在英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223139953b83bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223139953b83bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2592115813","title":"Mereo Biopharma Group Plc盘中异动 早盘快速上涨5.73%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592115813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592115813?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:32","pubTimestamp":1766154741,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日22时32分,Mereo Biopharma Group Plc股票出现波动,股价大幅上涨5.73%。截至发稿,该股报2.03美元/股,成交量16.5534万股,换手率0.10%,振幅1.30%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.60%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部在英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219223221953b753a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219223221953b753a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","MREO","BK4139"],"gpt_icon":0},{"id":"1175762210","title":"Mereo BioPharma第三季度净损失为702.4万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175762210","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175762210?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:19","pubTimestamp":1763572745,"startTime":"0","endTime":"0","summary":"11月10日 - Mereo BioPharma第三季度营业收入为-1001.5万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"1191882537","title":"Mereo BioPharma第三季度净收入为-702.4万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191882537","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191882537?lang=zh_cn&edition=full","pubTime":"2025-11-11 05:13","pubTimestamp":1762809235,"startTime":"0","endTime":"0","summary":"11月10日消息——Mereo BioPharma第三季度运营收入为-1001.5万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","MREO"],"gpt_icon":0},{"id":"2560597091","title":"Mereo Biopharma Group Plc2025财年第二财季实现净利润-14.79百万美元,同比减少20.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560597091","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560597091?lang=zh_cn&edition=full","pubTime":"2025-08-18 00:01","pubTimestamp":1755446518,"startTime":"0","endTime":"0","summary":"8月18日,Mereo Biopharma Group Plc公布财报,公告显示公司2025财年第二财季净利润为-14.79百万美元,同比减少20.54%;其中营业收入为505917.45美元,每股基本收益为-0.09美元。从资产负债表来看,Mereo Biopharma Group Plc总负债8.45百万美元,其中短期债务601000.00美元,资产负债比为7.42,流动比率为8.13。机构评级:截至2025年8月18日,当前有9家机构对Mereo Biopharma Group Plc目标价做出预测,其中目标均价为7.00美元,其中最低目标价为5.00美元,最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000431a48dec8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000431a48dec8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO"],"gpt_icon":0},{"id":"2517219192","title":"Mereo Biopharma Group Plc盘中异动 快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517219192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517219192?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:55","pubTimestamp":1741287354,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时55分,Mereo Biopharma Group Plc股票出现波动,股价急速下跌5.14%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.79%。其相关个股中,Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大,Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为4847.52%、3638.89%、254.59%,振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为125.28%、122.63%、71.44%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307025554989ee2d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307025554989ee2d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2517607614","title":"Mereo Biopharma Group Plc盘中异动 下午盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517607614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517607614?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:22","pubTimestamp":1741112566,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时22分,Mereo Biopharma Group Plc股票出现波动,股价急速拉升5.39%。截至发稿,该股报2.45美元/股,成交量103.912万股,换手率0.67%,振幅7.76%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.24%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030502224696397c89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030502224696397c89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","MREO","BK4139"],"gpt_icon":0},{"id":"2514085613","title":"Mereo Biopharma Group Plc盘中异动 早盘急速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514085613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514085613?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580274,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分,Mereo Biopharma Group Plc股票出现异动,股价快速拉升5.16%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.12%。其相关个股中,Enveric Biosciences, Inc.、Cns Pharmaceuticals, Inc.、Allarity Therapeutics, Inc.涨幅较大,Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为2625.96%、111.60%、85.05%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Silexion Therapeutics Corp、Eterna Therapeutics Inc.,振幅分别为6.75%、6.50%、6.37%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622311596314f07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622311596314f07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2514101657","title":"Mereo Biopharma Group Plc盘中异动 急速下跌5.02%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514101657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514101657?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:44","pubTimestamp":1740498297,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时44分,Mereo Biopharma Group Plc股票出现异动,股价急速下挫5.02%。截至发稿,该股报2.56美元/股,成交量87.9469万股,换手率0.57%,振幅7.06%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.94%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252344579630030e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252344579630030e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2514703855","title":"Mereo Biopharma Group Plc盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703855?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:23","pubTimestamp":1740428581,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时23分,Mereo Biopharma Group Plc股票出现异动,股价快速下挫5.09%。截至发稿,该股报2.71美元/股,成交量60.9798万股,换手率0.39%,振幅5.85%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.21%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225042301abdb57d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225042301abdb57d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2509496450","title":"Mereo Biopharma Group Plc盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509496450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509496450?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:24","pubTimestamp":1738700644,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时24分,Mereo Biopharma Group Plc股票出现波动,股价急速拉升5.02%。截至发稿,该股报3.14美元/股,成交量85.0602万股,换手率0.55%,振幅5.22%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为1.33%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205042404abc2683b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205042404abc2683b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","MREO","BK4139"],"gpt_icon":0},{"id":"2507320650","title":"Mereo Biopharma Group Plc盘中异动 快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507320650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507320650?lang=zh_cn&edition=full","pubTime":"2025-01-30 03:44","pubTimestamp":1738179895,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日03时44分,Mereo Biopharma Group Plc股票出现波动,股价急速上涨5.05%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为1.47%。其相关个股中,Silexion Therapeutics Corp、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大,Silexion Therapeutics Corp、60 Degrees Pharmaceuticals, Inc.、Vincerx Pharma, Inc.较为活跃,换手率分别为7151.78%、2355.25%、787.14%,振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical, Inc.、Silexion Therapeutics Corp,振幅分别为185.36%、120.82%、100.00%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130034455abbc9029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130034455abbc9029&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2506986498","title":"Mereo Biopharma Group Plc盘中异动 临近午盘大幅下跌5.00%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506986498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506986498?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:30","pubTimestamp":1737736221,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时30分,Mereo Biopharma Group Plc股票出现波动,股价大幅跳水5.00%。截至发稿,该股报2.95美元/股,成交量20.6662万股,换手率0.13%,振幅6.13%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.25%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125003021960fa28c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125003021960fa28c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2505026965","title":"Mereo Biopharma Group Plc盘中异动 急速拉升5.14%报3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505026965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505026965?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:59","pubTimestamp":1737665988,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时59分,Mereo Biopharma Group Plc股票出现波动,股价快速拉升5.14%。截至发稿,该股报3.07美元/股,成交量140.987万股,换手率0.91%,振幅7.71%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为1.74%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124045948abb6459e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124045948abb6459e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2505271670","title":"Mereo Biopharma Group Plc盘中异动 早盘快速上涨5.94%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505271670?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:42","pubTimestamp":1737470555,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时42分,Mereo Biopharma Group Plc股票出现波动,股价急速拉升5.94%。截至发稿,该股报3.03美元/股,成交量5.0591万股,换手率0.03%,振幅3.15%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.88%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224236960bbb82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224236960bbb82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO","BK4139","BK4505"],"gpt_icon":0},{"id":"2504650942","title":"Mereo Biopharma Group Plc盘中异动 下午盘股价大跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504650942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504650942?lang=zh_cn&edition=full","pubTime":"2025-01-17 04:06","pubTimestamp":1737058014,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日04时06分,Mereo Biopharma Group Plc股票出现异动,股价快速下跌5.61%。截至发稿,该股报2.86美元/股,成交量134.564万股,换手率0.87%,振幅5.10%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.77%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011704065496064a1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011704065496064a1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2503457436","title":"Mereo Biopharma Group Plc盘中异动 急速跳水5.69%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503457436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503457436?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:54","pubTimestamp":1736866484,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时54分,Mereo Biopharma Group Plc股票出现波动,股价大幅下跌5.69%。截至发稿,该股报3.15美元/股,成交量7.2824万股,换手率0.05%,振幅7.19%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.41%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114225444a221bde1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114225444a221bde1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mereobiopharma.com","stockEarnings":[{"period":"1week","weight":-0.1029},{"period":"1month","weight":-0.2152},{"period":"3month","weight":-0.7925},{"period":"6month","weight":-0.7757},{"period":"1year","weight":-0.8752},{"period":"ytd","weight":-0.0689}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mereo BioPharma Group plc于2015年3月10日根据英格兰和威尔士法律注册成立。该公司是一家专注于罕见病创新疗法开发的生物制药公司。它已经建立了一个后期临床候选产品组合,包括用于成骨不全症的setrusumab和用于α-1抗胰蛋白酶缺乏相关肺部疾病的alvelestat。该公司的战略涉及有选择地获取和开发通过先前研发取得进展的罕见病候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.015037},{"month":2,"riseRate":0.428571,"avgChangeRate":0.016104},{"month":3,"riseRate":0,"avgChangeRate":-0.177922},{"month":4,"riseRate":0.666667,"avgChangeRate":0.141069},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.12077},{"month":6,"riseRate":0.714286,"avgChangeRate":0.399821},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.055261},{"month":8,"riseRate":0.857143,"avgChangeRate":0.105012},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.100596},{"month":10,"riseRate":0.428571,"avgChangeRate":0.068788},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.101401},{"month":12,"riseRate":0.428571,"avgChangeRate":0.001557}],"exchange":"NASDAQ","name":"Mereo Biopharma Group Plc","nameEN":"Mereo Biopharma Group Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mereo Biopharma Group Plc(MREO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mereo Biopharma Group Plc(MREO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mereo Biopharma Group Plc,MREO,Mereo Biopharma Group Plc股票,Mereo Biopharma Group Plc股票老虎,Mereo Biopharma Group Plc股票老虎国际,Mereo Biopharma Group Plc行情,Mereo Biopharma Group Plc股票行情,Mereo Biopharma Group Plc股价,Mereo Biopharma Group Plc股市,Mereo Biopharma Group Plc股票价格,Mereo Biopharma Group Plc股票交易,Mereo Biopharma Group Plc股票购买,Mereo Biopharma Group Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mereo Biopharma Group Plc(MREO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mereo Biopharma Group Plc(MREO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}